Mycobacterium bovis Bacillus Calmette-Guérin killed by extended freeze-drying reduces colitis in mice

Gastroenterology

Volumn 141, Issue 2, 2011, Pages

  Lagranderie, Micheline ^a   Kluge, Christoph ^a   Kieferbiasizzo, Helene ^a   Abolhassani, Mohammad ^a   Nahori, Marieanne ^a   Fitting, Catherine ^a   Huerre, Michel ^a   Bandeira, Antonio ^b   Bercovier, Herve ^c   Marchal, Gilles ^a  

^a INSTITUT PASTEUR   (France)

^b Unité du Développement des Lymphocytes   (France)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

IL 10; Immune Regulation; Killed BCG; Therapeutic Vaccine

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD45RB ANTIGEN; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; OXAZOLONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CD4+ CD45+ T LYMPHOCYTE; COLITIS; COLON TUMOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FREEZE DRYING; INFLAMMATION; MALE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

EID: 80051509813     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.05.002     Document Type: Article

References (43)

1. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 2002 417 429 (Pubitemid 34851835)
2. K.A. Papadakis Chemokines in inflammatory bowel disease Curr Allergy Asthma Rep 4 2004 83 89 (Pubitemid 38899122)
3. A.C. Chin, and C.A. Parkos Transepithelial migration and epithelial barrier function in IBD potential targets for inhibiting neutrophil trafficking Ann N Y Acad Sci 1072 2006 276 287 (Pubitemid 44448460)
4. E.V. Loftus Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 126 2004 1504 1517 (Pubitemid 38649869)
5. J. Van Limbergen, D.C. Wilson, and J. Satsangi The genetics of Crohn's disease Annu Rev Genomics Hum Genet 10 2009 89 116
6. M.F. Neurath, S. Finotto, and L.H. Glimcher The role of Th1/Th2 polarization in mucosal immunity Nat Med 8 2002 567 573 (Pubitemid 34633433)
7. W. Strober, I.J. Fuss, and R.S. Blumberg The immunology of mucosal models of inflammation Annu Rev Immunol 20 2002 495 549 (Pubitemid 34293433)
8. M. Kawada, A. Arihiro, and E. Mizoguchi Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease World J Gastroenterol 13 2007 5581 5593 (Pubitemid 350031478)
9. L. Peyrin-Biroulet, P. Desreumaux, and W.J. Sandborn Crohn's disease: beyond antagonists of tumor necrosis factor Lancet 372 2008 67 81 (Pubitemid 351902263)
10. W.A. Stack, S.D. Mann, and A.J. Roy Randomised controlled trial of CDP571 antibody to tumor necrosis factor-alpha in Crohn's disease Lancet 349 1997 521 524 (Pubitemid 27092789)
11. M.J. Bevan, and P.J. Fink Immunology: surprising side effects Nature 454 2008 837 838
12. P. Desreumaux, L. Dubuquoy, and S. Nutten Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferators-activated receptor gamma (PPARgamma) heterodimer A basis for new therapeutic strategies J Exp Med 193 2001 827 838 (Pubitemid 32524532)
13. C.G. Su, X. Wen, and S.T. Bailey A novel therapy for colitis utilizing PPARγ ligands to inhibit the epithelial inflammatory response J Clin Invest 104 1999 383 389 (Pubitemid 29534322)
14. M.C. Fantini, C. Becker, and I. Tubbe Transforming growth factor beta induced Foxp3+ regulatory T cells suppress Th1 mediated experimental colitis Gut 55 2006 671 680
15. C. Asseman, S. Mauze, and M.W. Leach An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 1999 995 1004
16. M. Lagranderie, M. Abolhassani, and J. Vanoirbeek Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models J Allergy Clin Immunol 121 2008 471 478 (Pubitemid 351215172)
17. M. Lagranderie, M. Abolhassani, and J.A.J. Vanoirbeek Mycobacterium bovis bacillus Calmette-Guérin killed by extended freeze-drying target plasmacytoid dendritic cells to regulate lung inflammation J Immunol 184 2010 1062 1070
18. F.R. Byrne, and J.L. Viney Mouse models of inflammatory bowel disease Curr Opin Drug Discov Dev 9 2006 207 217
19. S. Melgar, L. Karlsson, and E. Rehnström Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease Int Immunopharmacol 8 2008 836 844
20. M. Boirivant, I.J. Fuss, and A. Chu Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 1998 1929 1939 (Pubitemid 28536780)
21. high T cells Eur J Immunol 31 2001 1465 1474 (Pubitemid 32454694)
22. H.S. Cooper, S. Murthy, and K. Kido Dysplasia and cancer in the dextran sulfate sodium mouse colitis model Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation Carcinogenesis 21 2000 757 768 (Pubitemid 30214034)
23. S. Wirtz, C. Neufert, and B. Weigmann Chemically induced mouse models of intestinal inflammation Nat Protoc 2 2007 541 546 (Pubitemid 47040018)
24. N. Eastaff-Leung, N. Mabarrack, and A. Barbour Foxp3(+) regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease J Clin Immunol 30 2010 80 89
25. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4 J Immunol 171 2003 5012 5017 (Pubitemid 37432781)
26. K. Yamazaki, M. Shimizu, and M. Okuno Synergistic effects of RXRγ and PPARγ ligands to inhibit growth in human colon cancer cells-phosphorylated RXRγ is a critical target for colon cancer management Gut 56 2007 1557 1563 (Pubitemid 350033194)
27. A. Izcue, J.L. Coombes, and F. Powrie Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation Immunol Rev 212 2006 256 271 (Pubitemid 44116713)
28. S. Huber, C. Schramm, and H.A. Lehr TGF-β signalling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells J Immunol 173 2004 6526 6531 (Pubitemid 39541034)
29. A. Di Sabatino, K.M. Pickard, and D. Rampton Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa Gut 57 2008 605 612 (Pubitemid 351579972)
30. I.J. Fuss, M. Boirivant, and B. Lacy The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis J Immunol 168 2002 900 908 (Pubitemid 34049594)
31. F. Cottrez, and H. Groux Regulation of TGF-β response during T cell activation is modulated by IL-10 J Immunol 167 2001 773 778 (Pubitemid 32660831)
32. T.R. Mosmann, and R.L. Coffman Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties Rev Immunol 7 1989 145 173 (Pubitemid 19138011)
33. M. Koch, G. Tucker-Heard, and N.R. Perdue The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation Nat Immunol 10 2009 595 602
34. W.S. Garrett, S. Punit, and C.A. Gallini Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells Cancer Cell 16 2009 208 219
35. W.S. Garrett, and L.H. Glimcher T-bet-/- GAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships Cytokine 48 2009 144 147
36. S. Aggarwal, N. Ghilardi, and M.H. Xie Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 2003 1010 1914
37. I.I. Ivanov, B.S. McKenzie, and L. Zhou The orphan nuclear receptor ROR-gammat directs the differentiation program of proinflammatory IL-17+ T helper cells Cell 126 2006 1121 1133 (Pubitemid 44380299)
38. S.J. Park, K.S. Lee, and S.R. Kim Peroxisome proliferators-activated receptor γ agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation J Immunol 183 2009 3259 3267
39. L. Dubuquoy, C. Rousseaux, and X. Thuru PPARγ as a new therapeutic target in inflammatory bowel diseases Gut 55 2006 1341 1349 (Pubitemid 44277368)
40. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657 (Pubitemid 46722637)
41. M. Lagranderie, M. Abolhassani, and J.A.J. Vanoirbeek Mycobacterium bovis bacillus Calmette-Guérin killed by extended freeze-drying target plasmacytoid dendritic cells to regulate lung inflammation J Immunol 184 2010 1062 1070
42. F.R. Byrne, and J.L. Viney Mouse models of inflammatory bowel disease Curr Opin Drug Discov Dev 9 2006 207 217
43. T. Arstila, T.P. Arstila, and S. Calbo Identical T cell clones are located within the mouse gut epithelium and lamina propria and circulate in the thoracic duct lymph J Exp Med 191 2000 823 834